Brigham and Women's Hospital: Diabetes Mellitus, Type 2 trials
The registry lists 40 Diabetes Mellitus, Type 2 studies with Brigham and Women's Hospital as lead sponsor. 3 are open to participants now and 6 have results posted.
Early Phase 1 1Phase 1 2Phase 2 5Phase 3 3Phase 4 2No phase 31(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Personalizing A1c Using Hematologic Indices and CGM for Accurate Diabetes DiagnosisNot yet recruitingNCT07111416
- NAD Augmentation in Diabetes Kidney DiseaseRecruitingNCT05759468Phase 2
- BESTMED: Observational Evaluation of Second Line Therapy Medications in DiabetesRecruitingNCT05161429
- Reinforcement Learning in Diabetes Mellitus TrialCompletedNCT04473326Not applicableResults posted
- Impact of Community Health Workers on Adherence to Therapy for Non-Communicable Chronic Disease in Chiapas, MexicoCompletedNCT02549495Results posted
- Study of Vitamin D and Omega-3 Supplementation for Preventing DiabetesCompletedNCT01633177Phase 3Results posted
- Role of Mineralocorticoid Receptor in Diabetic Cardiovascular DiseaseCompletedNCT00865124Not applicableResults posted
- The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 DiabetesTerminatedNCT00366301Phase 4Results posted
- Free Fatty Acids and Vascular Function in Subjects With DiabetesCompletedNCT00153179Phase 1/2Results posted
- Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular RiskCompletedNCT07619495
- Emulation of the EMPEROR-Preserved Trial Using Healthcare Claims DataCompletedNCT07599293
- Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data.CompletedNCT07417631
- INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)CompletedNCT07417618
- Comparative Effectiveness of Oral Semaglutide vs Sitagliptin Among Individuals With Heart Failure With Preserved Ejection Fraction (STEP-HFpEF DM ORAL)CompletedNCT07390110
- Comparative Effectiveness of Tirzepatide and Semaglutide in Individuals at Cardiovascular RiskCompletedNCT07096063
- Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims DataCompletedNCT07088718
- Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection FractionActive, not recruitingNCT06980623
- Emulation of the SUMMIT Heart Failure Trial in Healthcare Claims DataCompletedNCT06914154
- Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection FractionCompletedNCT06914141
- Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims DataCompletedNCT06914102
- Comparative Study of Tirzepatide Versus Dulaglutide (SURPASS CVOT) or Semaglutide on Major Cardiovascular Events in Participants With Type 2 DiabetesCompletedNCT06779929
- Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare ClaimsCompletedNCT06659744
- Emulation of the SOUL Diabetes Trial in Healthcare ClaimsCompletedNCT06659718
- Emulating the PIONEER6 Diabetes Trial Using Healthcare ClaimsCompletedNCT06659679
- Digital Health Navigation for Latino Patients With Type II DiabetesCompletedNCT06283992Not applicable
- Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney DiseaseActive, not recruitingNCT06190158Early Phase 1
- Refinement and Adaption of Reinforcement Learning to Personalize Behavioral Messaging for Healthy HabitsCompletedNCT05742685Not applicable
- Prediction of the SEPRA Diabetes Trial in Healthcare Claims DataCompletedNCT05577728
- Control:Diabetes Pilot Study ITerminatedNCT04158921Not applicable
- Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal InsulinStatus unknownNCT04034524
- Prediction of Findings From the Ongoing CAROLINA Trial Using Healthcare Database AnalysesCompletedNCT03648424
- Metformin And Cardiovascular Effectiveness vs SGLT2 (MACES)Status unknownNCT03627039
- Intensive Discharge Intervention in DiabetesCompletedNCT02122926Not applicable
- Detection of Diffuse Scar in Patients With DiabetesWithdrawnNCT01794091Phase 4
- Measurement of Eye Blood Flow and Renal Function in Healthy and Diabetic PatientsStatus unknownNCT01626469Phase 1/2
- Signaling Mechanisms and Vascular Function in Patients With Diabetes MellitusCompletedNCT00762671Phase 2/3
- Metabolomic Profiling of Novel Mediators of Vascular FunctionTerminatedNCT00762242
- Signaling Mechanisms and Vascular Function in Diabetes MellitusCompletedNCT00761852Phase 2/3
- VLDL and LDL Particle Types as Coronary Heart Disease Risk FactorsCompletedNCT00065793
- Dyslipidemia and Risk of Cardiovascular Disease in Diabetic Men and WomenCompletedNCT00037258